Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2014-07-15 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VILLIERS-SUR-MARNE (94350), Val-de-Marne
PHARMACIE DES TILLEULS : revenue, balance sheet and financial ratios
PHARMACIE DES TILLEULS is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VILLIERS-SUR-MARNE (94350),
this company of category PME
shows in 2023 a revenue of 2.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES TILLEULS (SIREN 803143932)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
2 632 107 €
N/C
N/C
N/C
1 815 760 €
1 699 433 €
1 689 533 €
Net income
277 937 €
270 768 €
113 932 €
253 137 €
146 252 €
127 768 €
180 436 €
152 451 €
158 562 €
EBITDA
N/C
N/C
197 417 €
N/C
N/C
N/C
243 097 €
208 446 €
259 233 €
Net margin
N/C
N/C
4.3%
N/C
N/C
N/C
9.9%
9.0%
9.4%
Revenue and income statement
In 2025, PHARMACIE DES TILLEULS generates positive net income of 278 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 159 k€ -> 278 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
277 937 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 80%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
80.426%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
47.382%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES TILLEULS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
151.784
99.379
66.265
50.168
473.789
213.203
197.974
117.567
80.426
Financial autonomy
32.651
42.987
51.082
57.674
15.06
27.398
27.564
39.152
47.382
Repayment capacity
3.494
1.708
2.311
None
None
None
6.288
None
None
Cash flow / Revenue
10.436%
9.972%
11.149%
None%
None%
None%
6.187%
None%
None%
Sector positioning
Debt ratio
80.432025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average-15 pts over 3 years
In 2025, the debt ratio of PHARMACIE DES TILLEULS (80.43) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
47.38%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average+17 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DES TILLEULS (47.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
6.29 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE DES TILLEULS (6.29) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 301.69. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
301.688
Liquidity indicators evolution PHARMACIE DES TILLEULS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
178.562
99.539
271.168
331.055
313.932
377.85
239.263
296.908
301.688
Interest coverage
5.104
4.876
3.659
None
None
None
3.196
None
None
Sector positioning
Liquidity ratio
301.692025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent+10 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DES TILLEULS (301.69) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
3.2x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of PHARMACIE DES TILLEULS (3.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES TILLEULS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
107 404 €
193 192 €
188 113 €
0 €
0 €
0 €
408 819 €
0 €
0 €
Inventory turnover (days)
28
26
25
0
0
0
20
0
0
Customer payment term (days)
0
3
7
0
0
0
3
0
0
Supplier payment term (days)
40
46
45
0
0
0
47
0
0
Positioning of PHARMACIE DES TILLEULS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DES TILLEULS is estimated at
4 415 062 €
(range 2 996 082€ - 6 927 840€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2996k€4415k€6927k€
4 415 062 €Range: 2 996 082€ - 6 927 840€
NAF 5 année 2025
Valuation method used
Net Income Multiple
277 937 €
×
15.9x
=4 415 062 €
Range: 2 996 082€ - 6 927 841€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES TILLEULS with other companies in the same sector:
Frequently asked questions about PHARMACIE DES TILLEULS
What is the revenue of PHARMACIE DES TILLEULS ?
The revenue of PHARMACIE DES TILLEULS in 2023 is 2.6 M€.
Is PHARMACIE DES TILLEULS profitable?
Yes, PHARMACIE DES TILLEULS generated a net profit of 278 k€ in 2025.
Where is the headquarters of PHARMACIE DES TILLEULS ?
The headquarters of PHARMACIE DES TILLEULS is located in VILLIERS-SUR-MARNE (94350), in the department Val-de-Marne.
Where to find the tax return of PHARMACIE DES TILLEULS ?
The tax return of PHARMACIE DES TILLEULS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES TILLEULS operate?
PHARMACIE DES TILLEULS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart